Please login to the form below

Not currently logged in
Email:
Password:

Claire Whitmarsh moves to Makara Health

She joins the leadership team as a director

Makara Health Claire WhitmarshUK-based healthcare communications agency Makara Health has boosted its leadership team with the appointment of Claire Whitmarsh as a director.

A healthcare communications specialist, Whitmarsh has over 20 years of industry experience with particular expertise in delivering strategic communications campaigns.

She has worked as an account director at Weber Shandwick and has held management positions at Cohn & Wolfe and Munro & Forster.

Whitmarsh also brings experience from AstraZeneca and Eli Lilly, where she consulted on internal, corporate and product communications.

Louise Sharp, owner and managing director of Makara Health, said: “We are delighted to have someone as passionate and experienced as Claire to join our senior-director-level service and work with the team to continue to build our offering.

“Claire brings invaluable depth and breadth in public relations, marketing communications, medical education, patient engagement and digital communications, along with a history of leading accounts and developing teams with great success.”

8th November 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...